Reckitt, Merck deal is off

Share this article:

Reckitt Benkiser is no longer interested in Merck's over-the-counter business. PM Live says reports indicate Merck may have wanted more than Reckitt was willing to spend for a portfolio of goods that includes items such as Coppertone sunscreen.

PM Live notes that the UK company was not the only interested bidder, and Bayer has also expressed an interest in taking on Merck's OTC unit.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.